WPath guidelines say puberty blockers are not a ‘nice to have’ defendants say.
Defendant says ‘time to think and alleviate distress’ is absolutely accurate way of describing purpose of puberty blockers
Judge quotes HRA investigation. Tavistock disagrees with HRA assessment.
Defendant says consent process robust - “if there’s concern, then they have to be resolved. There’s no proceeding” if concerns are not resolved
Defendant says what claimants submit “does violence to Montgomery.” Back on consent/competency. Defendant says what is material is what reasonable person in patient’s position would attach significance to. Defendants argue that abstract adult (a judge) is not reasonable person
Defendant says that Mr Hyam’s (claimants’ barrister) submission that someone can’t make a decision without relevant experience, undermines most consent decisions.
Defendant says fertility is discussed with YP
Judge questions what would constitute sufficient understanding of sexual functioning, defendant says if 11 year old didn’t know what an erection was, what an orgasm was, then they would not be deemed capable of giving consent
That person would then be helped to improve their understanding and would be reassessed.
Assessment for cross sex hormones - oestrogen and testosterone - involve a whole new process and more discussion, defendant says
Younger ‘clients’ would have more appointments before being referred to endocrinology. Average age of referral though is 15.4 years, Tavistock says
Appointments must also be spaced over a ‘significant period of time’.
Service specification states first appointment should be within four months. At the moment it’s about two years
Judge clarifies referrals figures - over half of those referred to endocrinology for blockers were under 16, over a quarter were under 14
Defendant says On average younger patients had 10 to 11 appointments before being referred
Information provided by GIDS to children and families emphasises it’s entirely up to them whether to go onto puberty blockers. They are presented with benefits and possible disadvantaged and are told, “please think carefully about the advantages & disadvantages before you decide”
Defendant says there are instances where GIDS refer to endocrine clinic, but where endocrine clinic do not think child can give consent and will refer back.
Tavistock client N talked about - understood their options and the impact puberty blockers would have on body, mood, fertility options were discussed with me. ‘I never felt pressured to go on the treatment... the treatment with puberty blockers may very well have saved my life’
Referring to case law, defendant says law should be simple and clear. That one particular treatment - puberty blockers - be carved out, is contradictory. Furthermore, a whole raft of legislation recognises the age of 16 as a threshold. Claimant is arguing under 18s can’t consent
Tavistock emphasises the autonomy of the child, defendant says. Asked about the 11 year old who wants treatment but can’t consent, defendant wants to consult with Tavi team. Currently, Tavi has never taken an application to court when it comes to treatment with blockers
Judge questions defendants understanding of gillick competency. The application of Montgomery does not fit in with the analysis, she says
Defendant argues that what is salient is key and that is person and context specific. Two dimensions to what is salient - for the individual person, and for the treatment. Defendant argues Tavistock process takes these into account and helps recognise whether YP can give consent
Judge asks again about the 11 year old, with little understanding of sexual functioning and don’t have a basis of experience. Defendant says job of clinicians is to help facilitate understanding in process of dialogue. To make sure they understand what is salient...
If they don’t then more time will be given. Judge presses again what about the three 10/11 year olds who were referred for blockers last year. On what basis were they judged as being competent?
Defendant says 10 yo at tanner stage 2, 10 appointments and discussion with child and families, and then decision reached. We don’t have the circumstances of those cases in front of us. They were all properly clinically made decisions.‘Nothing inherently unlawful in that process’
Responding to point raised by claimant yesterday that court can override the decision of a child, defendant says it can only be done in very narrow circumstances: threat to life or grave risk of severe mental or physical harm. Those are not met in this case, they say
Defendant says court cannot declare that process used by Tavistock for referral for hormone blockers is unlawful
To rule that under 18s cannot give consent would run entirely contrary to existing law and precedent
To apply to court of protection in every case where treatment of puberty blockers is wanted, even where all parties are agreed - In these circumstances, defendant argues, court has no jurisdiction. Plus court of protection not right vehicle.
Judge raises question of 10 year old given puberty blockers, then wants to sue aged 19. The YP says ‘you never should have done that to me’ as part of a medical negligence claim.
Barrister for Tavistock has now finished. Now the barrister who represents the hospitals who provide the Endocrinology services to GIDS patients
Barrister: the 10 yo girl who has started periods. She understands her body has changed. She has gender dysphoria, but knows that she can alleviate distress by taking blocker. The issues of fertility don’t need to be discussed at this point. 10yo could begin stage 1 blockers...
Then, say, at 14, she could come off the blocker to have eggs frozen etc. From endocrinologist perspective, stage 1 is reversible. Could pause then have eggs harvested, and then go onto surgery much later if they wanted.
We say a 10 year old does have gillick competency. They understand their bodies. They understand their gender dysphoria and it causes them distress.
‘There is no alternative treatment’ counsel for hospitals says
Very few 10yo have blockers - they’re mostly natal girls - but we do think they can give consent
Judge asks whether experience of being on blocker will effect the later 14yo decision-making process? Barrister says they will have matured and be in a better position to understand
Judge presses whether having puberty suppressed will impact on decision making. Barrister says it’s a long pathway. If you go on blocker at 10, you have to wait 6 years for cross sex hormones
Another judge says what you will not have gained is experience of what it’s like to live in the body you were born with though...
Accepts that aspect but whole purpose of NHS commissioning this service is to alleviate suicidal ideation and gender dysphoria
Endocrinologists at UCLH and a leeds are experienced, the former doing this since 2006. They have treated hundreds of distressed children in stage 1. It’s their view that it can and does alleviate the distress of the dysphoria.
Judge cites the early intervention study which suggests no overall improvement in psychological well-being. Barrister says endocrinologists’ view is that the hormone blockers are alleviating distress.
Judge asks what has happened to the publication of the results of the early intervention study, given it ended in February 2019? Barrister for Tavi says it’s going through peer review process. Judge says, ‘why can’t we see it then?’
There’s no reason in law why parental responsibility is not sufficient. In practice, we take parental consent. If we fail to persuade you that children as young as 10 are Gillick competent then there would need to be a discussion between endocrinologists & Tavistock
But in the eyes of the law, if someone sued my endocrinologists, ‘I would be shouting parental responsibility’ all through the claim.
Barrister says no role whatsoever for the court of protection.
Just to explain there are three judges hearing this case - THE PRESIDENT OF THE QUEENS BENCH DIVISION and LORD JUSTICE LEWIS and MRS JUSTICE LIEVEN DBE - I’m unable to clarify which is questioning on any given occasion. It’s too time consuming for the purposes of tweeting
Some clarifications on earlier points. Of 161 referrals to endocrinology for puberty blockers last year, break down by age is:
10/11 - 3
12 - 13
13 - 10
14 - 24
15 - 45
16 - 51
17/18 - 15
So in fact fewer than a quarter were under 14
The Tavistock have informed me that this number is the average across all ages. They say that recent analysis shows that there were 13.3 appointments on average for young people aged 10 and 11. None received fewer than 9 appointments before referral to endocrinology.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Court has resumed after lunch. Barrister for endocrinologists explains:
For UCL, median age for blockers 14.6, for cross sex hormones 17.4, youngest 10
For Leeds, median age for blockers 16, cross sex hormones 17.2, youngest 12
Of 145 patients referred to Leeds, 38 experienced delays to treatment. On two occasions pressure was seen to be coming from parent and choice not freely made. Barrister says evident there is no immediate access to treatment after referral
Barrister for endocrinologists says the relevant information on risks/benefits is very different for stage 1 (blockers) and 2 (cross sex hormones). ‘It’s no answer to say the majority of patients do go from stage 1 to stage 2.’
Citing Dutch team again, “concerns have been raised that blocking treatment itself may increase the persistence of gender dysphoria”, but adds that we don’t know this yet.
Medium and long terms consequences of starting blocker treatment, it’s argued, include:
Inability to orgasm, compromised cognitive function, lifelong need for medication, repeated surgical intervention.
Case being made by Bell is that the blocker is not fully physically reversible, as claimed.
THREAD: In May '19 @BBCNewsnight requested a copy of a 2005 review of the Gender Identity Development Unit - now GIDS - via the FOI Act. Many months later, we’ve now published some its findings and recommendations:
WATCH: bbc.in/33ixth5
READ: bbc.in/30vvJiO
1/
The review was carried out by Dr David Taylor, then medical director of the Tavistock and Portman NHS Foundation Trust, between May and October 2005. Its findings were published internally in January 2006. He spoke with members of the team, the wider Trust & endocronologists
2/
Dr Taylor stresses that staff were doing all they could to help their patients, who were often very distressed. They took the work very seriously. But, his report went on to detail several areas that he believed needed addressing.
3/
In November 2019, we made two pieces on detransitioning – for @BBCNewsnight and @BBCfileon4. They featured ‘Debbie, ’ who began transitioning to a man at the age of 44.
She had been given testosterone at her first appointment, and completed a full surgical transition over a number of years. She changed her name legally to Lee. When we spoke, Debbie had taken the decision, after 17 years, to stop her testosterone injections.
She wanted to detransition and posed the question, “how the hell do I go back to being the Debbie that I was?” Speaking then, Debbie was unsure about what the long-term implications may be for her and talked about the possibility of reversing some of her surgery.
THREAD: New information has emerged on details of allegations being made in legal action being taken against the Tavistock and Portman NHS Foundation Trust by its own Safeguarding Children Lead.
In June @BBCNewsnight broadcast concerns raised by Gender Identity Development Service staff during an official review of the service by the medical director of the Tavistock and Portman NHS Foundation Trust
WATCH IN FULL: bbc.in/2NaXIx1
READ: bbc.in/3hSuH7A
We (@deb_cohen and I) had exclusive sight of several official transcripts of interviews that took place between front-line staff and the Trust’s medical director. The findings of the review were published in Spring 2019.